Vaishali Pharma Ltd

Vaishali Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 Feb 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 02 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

At Rs 7.55, sellers were still queuing — but there were no buyers willing to take the other side. Vaishali Pharma Ltd locked at its lower circuit of 5% on 30 Apr 2026, with unfilled sell orders and a frozen price, signalling persistent selling pressure in a micro-cap stock with limited liquidity.

At Rs 7.88, sellers were still queuing — but there were no buyers willing to take the other side. Vaishali Pharma Ltd locked at its lower circuit of 4.95% on 24 Apr 2026, with unfilled sell orders and a frozen price, reflecting persistent selling pressure in a micro-cap stock with limited liquidity.

At Rs 9.30, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Vaishali Pharma Ltd locked at its upper circuit of 20% on 21 Apr 2026, with buyers queuing and no sellers willing to part with shares.

Vaishali Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 Feb 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 21 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

At Rs 7.86, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Vaishali Pharma Ltd locked at its upper circuit of 9.47% on 17 Apr 2026, with buyers queuing and no sellers willing to part with shares.

Vaishali Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 Feb 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 10 April 2026, providing investors with an up-to-date view of the company’s performance and outlook.

At Rs 5.85, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Vaishali Pharma Ltd locked at its upper circuit of 19.88% on 1 Apr 2026, with buyers queuing and no sellers willing to part with shares.

Vaishali Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 Feb 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 30 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Vaishali Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 February 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 16 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Vaishali Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 Feb 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 04 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Vaishali Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 February 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 20 February 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Vaishali Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 February 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 February 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Vaishali Pharma Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 06 Feb 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 29 January 2026, providing investors with the latest perspective on its performance and prospects.

Vaishali Pharma Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 06 February 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 January 2026, providing investors with the latest insights into its performance and outlook.

Vaishali Pharma Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 06 Feb 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with the latest insights into its performance and outlook.

Vaishali Pharma has experienced a revision in its market evaluation, reflecting a more cautious outlook from analysts. This shift comes amid ongoing challenges in the company’s financial and technical indicators, alongside valuation concerns, signalling increased risk for investors in the Pharmaceuticals & Biotechnology sector.